Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rapport Therapeutics
Biotech
MHRA CEO Raine to depart in Autumn —Chutes & Ladders
Top UK medicines regulator to depart. New Pfizer Ventures chief starts. Ionis hires a familiar face for top strategy job.
Max Bayer
,
Annalee Armstrong
Mar 1, 2024 9:30am
Illumina nets new CEO—Chutes & Ladders
Sep 8, 2023 9:30am
Rapport finds the right words to talk investors into $150M more
Aug 23, 2023 6:00am
Biogen taps new board chair—Chutes & Ladders
Mar 10, 2023 9:30am
Third Rock, J&J neuroscience spinout Rapport arrives with $100M
Mar 7, 2023 9:05am